Role of CYP1B1Retinoid in Congenital Glaucoma

Ivaylo Stoilov, MD
University of Connecticut Health Ctr (Farmington, CT)
Year Awarded:
2001
Grant Duration:
April 1, 2001 to March 31, 2003
Disease:
Glaucoma
Award Amount:
$50,000
Grant Reference ID:
G2001021
Award Type:
Standard
Award Region:
US Northeastern

Role of CYP1B1Retinoid in Congenital Glaucoma

Summary

 

Details


Some newborns and infants are affected by an especially severe form of glaucoma called Primary Congenital Glaucoma (PCG). PCG is caused by an abnormal development of the anterior chamber angle of the eye. In previous studies, Dr. Stoilov has found that this disease is caused by mutations in the gene for Cytochrome P4501B1 (CYPlBl). Humans have more than fifty different cytochrome P450 genes. They are responsible for the synthesis of various hormones and for detoxifying drugs, alcohol, and other chemicals. Based on the substrate specificity of CYPlBl, Dr. Stoilov hypothesizes that CYP1B1 affects a little-known retinoid signaling pathway operating during the later stages of eye development. Dr. Stoilov's goal is to identify the enzymes involved in the CYPlBl pathway and study their expression during the development of the anterior chamber angle of the eye.

Publications

Stoilov, I. (2001) Cytochrome P450s: coupling development and environment. Trends in Genetics. 17:629-632  
 

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.